Prudential Financial
CNCE

Prudential Financial’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Prudential Financial’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-259,245
Closed -$3.28M – 2547
2020
Q4 		$3.28M Sell
259,245
-27,950
-10% -$319K 0.01% 1186
2020
Q3 		$2.82M Sell
287,195
-20,437
-7% -$201K 0.01% 1165
2020
Q2 		$3.06M Sell
307,632
-17,561
-5% -$168K 0.01% 1158
2020
Q1 		$2.88M Sell
325,193
-42,600
-12% -$420K 0.01% 1176
2019
Q4 		$3.39M Sell
367,793
-13,156
-3% -$93.2K 0.01% 1330
2019
Q3 		$2.24M Buy
380,949
+28,611
+8% +$304K ﹤0.01% 1539
2019
Q2 		$4.23M Buy
352,338
+221,512
+169% +$2.38M 0.01% 1229
2019
Q1 		$1.58M Buy
130,826
+49,210
+60% +$725K ﹤0.01% 1709
2018
Q4 		$1.02M Buy
81,616
+1,610
+2% +$22.2K ﹤0.01% 1796
2018
Q3 		$1.19M Sell
80,006
-2,856
-3% -$44.9K ﹤0.01% 1817
2018
Q2 		$1.4M Buy
82,862
+8,958
+12% +$174K ﹤0.01% 1801
2018
Q1 		$1.69M Buy
73,904
+22,461
+44% +$500K ﹤0.01% 1670
2017
Q4 		$1.33M Sell
51,443
-13,467
-21% -$271K ﹤0.01% 1746
2017
Q3 		$958K Sell
64,910
-33,720
-34% -$489K ﹤0.01% 1850
2017
Q2 		$1.38M Sell
98,630
-154,500
-61% -$2.28M ﹤0.01% 1721
2017
Q1 		$4.32M Buy
253,130
+52,500
+26% +$630K 0.01% 1185
2016
Q4 		$2.06M Sell
200,630
-7,900
-4% -$72.2K ﹤0.01% 1535
2016
Q3 		$2.11M Sell
208,530
-22,460
-10% -$245K ﹤0.01% 1487
2016
Q2 		$2.59M Sell
230,990
-10,800
-4% -$138K ﹤0.01% 1431
2016
Q1 		$3.3M Buy
241,790
+24,690
+11% +$355K 0.01% 1314
2015
Q4 		$4.12M Buy
217,100
+124,200
+134% +$2.7M 0.01% 1163
2015
Q3 		$1.74M Buy
+92,900
New +$1.58M ﹤0.01% 1514

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential Financial's CNCE Position: Q1 2021 in Review

Prudential Financial sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2021, closing a stake of 259,245 shares — an estimated $3.28M sold.

Prudential Financial first reported a position in CNCE in Q3 2015 and held it in 22 quarters. The position peaked at $4.32M in Q1 2017. 91 funds tracked by Wall St. Rank hold CNCE as of Q1 2021.

  • Prudential Financial reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Prudential Financial sold 259,245 Concert Pharmaceuticals, Inc. shares in Q1 2021, an estimated $3.28M.
  • Prudential Financial first reported a position in Concert Pharmaceuticals, Inc. in Q3 2015 and held it in 22 quarters.
  • Prudential Financial's Concert Pharmaceuticals, Inc. position peaked at $4.32M in Q1 2017.
  • 91 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2021.

Based on Prudential Financial's 13F filing for Q1 2021, filed 12 May 2021.